MADISON NIEDERER: Open Payments
NPI 1245011881 · NORTON SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 29 payments from 20 companies in 2025. Trend: 2023 $78 · 2024 $800 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| JAZZ PHARMACEUTICALS INC. | 2 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| ABBVIE INC. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Lilly USA, LLC | 2 | $46 |
| SpringWorks Therapeutics, Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $30 |
Products named: TIVDAK, ZEPZELCA, IMFINZI, VENCLEXTA, VERZENIO, OGSIVEO, ICLUSIG, Fabhalta.
Industry payments across MI — which companies pay providers there.
